New York, USA, Jan. 31, 2023 (GLOBE NEWSWIRE) -- The Global Diabetic Wounds Market is Projected to Boost at a Growth Rate of ~7% by 2027 | DelveInsight
The diabetic wounds market is experiencing positive growth as a result of rising diabetes prevalence, an increase in diabetic foot ulcers among the population, the launch of novel active therapies, and an increase in the number of amputations due to diabetic foot ulcers, all of which are contributing to the diabetic wounds market growth during the forecast period of 2022–2027.
DelveInsight’s Diabetic Wounds Market Insights report provides the current and forecast market analysis, individual leading diabetic wounds companies’ market shares, challenges, diabetic wounds market drivers, barriers, and trends, and key diabetic wounds companies in the market.
Key Takeaways from the Diabetic Wounds Market Report
- As per DelveInsight estimates, North America is anticipated to dominate the global diabetic wounds market during the forecast period.
- Notable diabetic wounds companies such as B Braun Meslungen AG, MEDCu, 3M, Integra LifeSciences., Organogenesis Inc, Bharat Biotech, RLS Global, Coloplast Corp, ConvaTec Inc., Cardinal Health, BSN medical Inc, HARTMANN USA, Inc, Mil Laboratories, Hollister Incorporated, DermaRite Industries, LLC, Mölnlycke Health Care AB, Osiris (Smith&Nephew), Lohmann & Rauscher, Medela AG, DeRoyal, and several others are currently operating in the diabetic wounds market.
- In December 2022, Recce Pharmaceuticals Ltd received HREC approval to begin its Phase I/II clinical trial evaluating RECCE® 327 as a spray-on, broad-spectrum antibiotic therapy for mild skin and soft tissue diabetic foot infections (DFI).
- In April 2022, MiMedx Group, Inc., a transformational placental biologics company, announced today that it will sponsor a lunch symposium at the Symposium on Advanced Wound Care (SAWC) Spring, which will take place from April 6-10 in Phoenix, Arizona.
- In April 2021, Joerns Healthcare and Medela announced a nationwide partnership to develop access to innovative negative pressure wound therapy systems. Through this agreement, Joerns will expand its wound care portfolio to include the full Medela line of negative pressure wound therapy products, including the Invia Liberty and Invia Motion 60 NPWT Systems.
To read more about the latest highlights related to the diabetic wounds market, get a snapshot of the key highlights entailed in the Global Diabetic Wounds Market Report
Diabetic Wounds Overview
Diabetes is caused by the body’s inability to produce or use insulin. Insulin is a hormone that aids the body in converting sugar (glucose) to energy. If your body has difficulty metabolizing glucose, you may experience high blood sugar levels. This could affect the body’s ability to heal wounds. Diabetes causes wounds to heal more slowly and develop more rapidly. Cuts, grazes, scratches, and blisters can occur anywhere on the body, but they are most common on foot. A minor cut on foot can quickly develop into a foot ulcer. Foot ulcers can be dangerous if left untreated. Diabetes causes approximately 15% of people to develop foot ulcers.
Diabetic Wounds Market Insights
North America is expected to account for the largest share of the global diabetic wounds market. The rising prevalence of diabetic foot ulcers in North America is expected to boost the region’s diabetic wound treatment market. Furthermore, the presence of key players such as 3M company, Coloplast, Cardinal Health, and others in the region is expected to boost the diabetic wounds market in the region. In addition, the launch of programs by leading wound care expert companies will contribute to the region’s diabetic wounds market growth.
To know more about why North America is leading the market growth in the diabetic wounds market, get a snapshot of the Diabetic Wounds Market Outlook
Diabetic Wounds Market Dynamics
The rising prevalence of diabetes among the global population is expected to increase demand for diabetic wound treatment therapies and associated devices. This is because uncontrolled diabetes mellitus can lead to the development of diabetic wounds, particularly diabetic foot ulcers, in the general population. Furthermore, rising diabetes cases in low and middle-income countries could lead to diabetic wounds in these patients, ultimately leading to diabetic wounds market growth.
However, the high cost of ulcer management and stringent treatment device regulations may be limiting factors in the diabetic wounds market growth.
Additionally, the ongoing COVID-19 pandemic has impacted the diabetic wounds market. This is because healthcare systems all over the world are struggling to provide diabetic foot services to patients. Furthermore, social distancing and safeguarding public health guidelines have influenced the delivery of diabetic foot treatment services.
Get a sneak peek at the diabetic wounds market dynamics @ Diabetic Wounds Market Dynamics Analysis
| Report Metrics | Details |
| Coverage | Global |
| Study Period | 2019–2027 |
| Base Year | 2021 |
| Diabetic Wounds Market CAGR | ~7% |
| Projected Diabetic Wounds Market Size by 2027 | USD 3.44 Billion |
| Key Diabetic Wounds Companies | B Braun Meslungen AG, MEDCu, 3M, Integra LifeSciences., Organogenesis Inc, Bharat Biotech, RLS Global, Coloplast Corp, ConvaTec Inc., Cardinal Health, BSN medical Inc, HARTMANN USA, Inc, Mil Laboratories, Hollister Incorporated, DermaRite Industries, LLC, Mölnlycke Health Care AB, Osiris (Smith&Nephew), Lohmann & Rauscher, Medela AG, DeRoyal, among others |
Diabetic Wounds Market Assessment
- Diabetic Wounds Market Segmentation
- Market Segmentation By Product Type: Wound Care Dressings (Foam Dressings, Antimicrobial Dressings, Hydrogel Dressings, Alginate Dressings, Silver Dressings, Hydrocolloid Dressings, Hydro Fiber Dressings, Others), Wound Care Devices (Negative Pressure Wound Therapy Devices, Hyperbaric & Oxygen Therapy Devices, Debridement Devices, Others), Skin Grafts & Substitutes, Growth Factors, Others
- Market Segmentation By Wound Type: Neuropathic Ulcer Wounds, Ischemic Ulcer Wounds, Neuro-Ischemic Ulcer Wounds
- Market Segmentation By End User: Hospitals, Specialty Clinics, Others
- Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
- Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View
Which MedTech key players in the diabetic wounds market are set to emerge as the trendsetter explore @ Diabetic Wounds Companies
Table of Contents
| 1 | Report Introduction |
| 2 | Executive summary |
| 3 | Regulatory and Patent Analysis |
| 4 | Key Factors Analysis |
| 5 | Porter’s Five Forces Analysis |
| 6 | COVID-19 Impact Analysis on Diabetic Wounds Market |
| 7 | Diabetic Wounds Market Layout |
| 8 | Global Company Share Analysis – Key 3-5 Companies |
| 9 | Diabetic Wounds Market Company and Product Profiles |
| 10 | Project Approach |
| 11 | About DelveInsight |
Interested in knowing the diabetic wounds market by 2027? Click to get a snapshot of the Diabetic Wounds Market Trends
Related Reports
Type 1 Diabetes Market Insights, Epidemiology, and Market Forecast – 2032 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key type 1 diabetes companies including Histogen, Novo Nordisk, Prevention Bio, among others.
Type 1 Diabetes Epidemiology Forecast
Type 1 Diabetes Epidemiology Forecast – 2032 report delivers an in-depth understanding of the disease, historical and forecasted type 1 diabetes epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Diabetes Pipeline Insights – 2023 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key diabetes companies, including Prevention Bio, Zealand Pharma, Novo Nordisk, among others.
Diabetes Market Insights, Epidemiology, and Market Forecast – 2032 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key diabetes companies, including TikoMed, Avotres, REMD Biotherapeutics, Novo Nordisk, among others.
Type 2 Diabetes Market Insights, Epidemiology, and Market Forecast – 2032 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key type 2 diabetes companies, including Sanofi, Eli Lilly and Company, AstraZeneca, Novartis, among others.
Type 2 Diabetes Pipeline Insight – 2023 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key type 2 diabetes companies, including Sanofi, Eli Lilly and Company, Novartis, among others.
Other Trending Reports
Treatment Resistant Depression Market | Advanced Renal Cell Carcinoma Market | Brain Cancer Market | Centronuclear Myopathy Market | Head And Neck Squamous Cell Carcinoma Market | Acquired Immunodeficiency Syndrome Market | Acute Intermittent Porphyria Market | Neurovascular Devices Market | Defibrillators Market | Ventricular Hypertrophy Market | Urolithiasis Market | Alopecia Areata Market | Autonomic Dysfunction Market | Acute Ischemic Stroke Ais Market | Adenoid Cystic Carcinoma Market | Aspergillosis Market | Biliary Atresia Market | Biliary Tumor Market | Chronic Inducible Urticaria Market | Chronic Insomnia Market | Critical Limb Ischemia Market | Endometriosis Pain Market | Generalized Anxiety Disorder Gad Market | Hallux Valgus Market | Hemophilia B Market | Immunologic Deficiency Syndrome Market | Neuroblastoma Market | Neuromodulation Devices Market | Neurovascular Thrombectomy Devices Market | Osteosarcoma Market | Pemphigus Vulgaris Market | Progressive Familial Intrahepatic Cholestasis Market | Pruritus Market | Radiation Toxicity Market | Pulmonary Hypertension Associated With Interstitial Lung Disease Market | Cluster Headaches Market | Foot And Ankle Devices Market | Intravenous Immunoglobulin Market | Bile Duct Neoplasm Market | Blood Glucose Monitoring Systems Market | Rett Syndrome Market | Tissue Heart Valves Market | Cardiac Biomarkers Testing Devices Market | Subscription Healthcare | Hepatorenal Syndrome Market | Central Venous Catheters Market | Continuous Renal Replacement Therapy Machines Market | Nonalcoholic Steatohepatitis Market | Necrotizing Enterocolitis Market | Cardiac Amyloidosis Market | Artificial Iris Market | Aortic Aneurysm Stent Grafts Market | Polypoidal Choroidal Vasculopathy Market | Adrenal Crisis Market | Hearing Implants Market | Image Guided Surgery Devices Market | Angioedema Market | Bladder Cancer Market
Related Healthcare Blogs
Evolution in Diabetes Management
Increasing Prevalence of Diabetes
Related Healthcare Services
Healthcare Competitive Intelligence Services
Healthcare Asset Prioritization Services
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.
